<?xml version="1.0" encoding="UTF-8"?>
<ref id="B19-molecules-26-01252">
 <label>19.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Ansari</surname>
    <given-names>M.N.</given-names>
   </name>
   <name>
    <surname>Aloliet</surname>
    <given-names>R.I.</given-names>
   </name>
   <name>
    <surname>Ganaie</surname>
    <given-names>M.A.</given-names>
   </name>
   <name>
    <surname>Khan</surname>
    <given-names>T.H.</given-names>
   </name>
   <name>
    <surname>Rehman</surname>
    <given-names>N.</given-names>
   </name>
   <name>
    <surname>Imam</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Hamad</surname>
    <given-names>A.M.</given-names>
   </name>
  </person-group>
  <article-title>Roflumilast, a phosphodiesterase 4 inhibitor, attenuates cadmium induced renal toxicity via modulation of NF-ÎºB activation and induction of NQO1 in rats</article-title>
  <source>Human Exp. Toxicol.</source>
  <year>2019</year>
  <volume>38</volume>
  <fpage>588</fpage>
  <lpage>597</lpage>
  <pub-id pub-id-type="doi">10.1177/0960327119829521</pub-id>
 </element-citation>
</ref>
